Sartorius sets out plans for Ambr after Tap takeover
Sartorius has confirmed it will make the Ambr microreactor technology it acquired with Tap Biosystems compatible with its own downstream processing systems.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs